for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BRIEF-Aralez sees 2018 net revenues $140 mln to $160 mln

Nov 9 (Reuters) - Aralez Pharmaceuticals Inc

* Aralez announces third quarter 2017 financial results and achieves profitability on an adjusted EBITDA basis for the first time in the third quarter

* Aralez Pharmaceuticals Inc - provides updated 2017 full-year guidance and preliminary 2018 full-year outlook

* Aralez Pharmaceuticals Inc - plans to implement further financial improvements designed to streamline U.S. business

* Aralez Pharmaceuticals Inc - net loss in Q3 of 2017 was $24.4 million, or $0.37 per diluted share

* Qtrly total revenues, net $24.3 million versus $13.6 mln

* Aralez Pharmaceuticals Inc - updated 2017 net revenues to be in a range of $95 million to $105 million

* Aralez Pharmaceuticals Inc - sees 2018 net revenues $140 million to $160 million Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up